Correlation Between GlaxoSmithKline PLC and 15089QAP9

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and 15089QAP9 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and 15089QAP9 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and CE 6379 15 JUL 32, you can compare the effects of market volatilities on GlaxoSmithKline PLC and 15089QAP9 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of 15089QAP9. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and 15089QAP9.

Diversification Opportunities for GlaxoSmithKline PLC and 15089QAP9

0.82
  Correlation Coefficient

Very poor diversification

The 3 months correlation between GlaxoSmithKline and 15089QAP9 is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and CE 6379 15 JUL 32 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CE 6379 15 and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with 15089QAP9. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CE 6379 15 has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and 15089QAP9 go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and 15089QAP9

Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to generate 1.46 times more return on investment than 15089QAP9. However, GlaxoSmithKline PLC is 1.46 times more volatile than CE 6379 15 JUL 32. It trades about 0.01 of its potential returns per unit of risk. CE 6379 15 JUL 32 is currently generating about 0.0 per unit of risk. If you would invest  3,410  in GlaxoSmithKline PLC ADR on August 28, 2024 and sell it today you would earn a total of  5.00  from holding GlaxoSmithKline PLC ADR or generate 0.15% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy96.57%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  CE 6379 15 JUL 32

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
CE 6379 15 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CE 6379 15 JUL 32 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, 15089QAP9 is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

GlaxoSmithKline PLC and 15089QAP9 Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and 15089QAP9

The main advantage of trading using opposite GlaxoSmithKline PLC and 15089QAP9 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, 15089QAP9 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 15089QAP9 will offset losses from the drop in 15089QAP9's long position.
The idea behind GlaxoSmithKline PLC ADR and CE 6379 15 JUL 32 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Global Correlations
Find global opportunities by holding instruments from different markets
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing